Amvis Holdings Inc
Amvis Holdings Inc maintains a capital structure with a debt-to-equity ratio of 1.11, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.12, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -4.385 billion JPY, which may signal potential liquidity constraints in the near term. In terms of profitability, Amvis Holdings Inc reports a return on equity (ROE) of 10.13% and a return on assets (ROA) of 4.36%. These figures are in line with the industry's preferred metrics, which emphasize ROE and ROA as key indicators of financial performance. The company's net income of 3.66 billion JPY and operating income of 5.504 billion JPY reflect a solid operational performance, although the gross profit margin of 30.08% (14.789 billion JPY on 49.174 billion JPY revenue) suggests there is room for improvement in cost management. Geographically, Amvis Holdings Inc's revenue is concentrated in Japan, as indicated by the JPY-based financials. The company does not disclose specific segment revenues, but its primary business activity is in pharmaceuticals. This concentration may expose the company to regional economic and regulatory risks, particularly in the healthcare sector. The company's growth trajectory is modest, with no specific numeric deltas provided for the current or next fiscal year. However, the capital expenditure of -10.424 billion JPY indicates a significant investment in long-term assets, which could support future growth. The company's operating cash flow of 6.026 billion JPY provides a buffer for these investments and ongoing operations. Risk factors for Amvis Holdings Inc include a medium liquidity risk, as highlighted by the negative net cash position after subtracting total debt. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The risk assessment also notes that the company's liquidity position is a key flag, which may require monitoring in the coming periods. Recent events and filings for Amvis Holdings Inc do not include specific details in the provided data. However, the company's financial statements and disclosures are available for further review. The absence of recent significant events or transcripts does not imply a lack of activity but rather a need to consult additional sources for the most up-to-date information.
Business. Amvis Holdings Inc operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
Classification. Amvis Holdings Inc is classified under the Healthcare Facilities & Services industry within the Healthcare Services & Equipment business sector, with a classification confidence of 0.92.
- Amvis Holdings Inc has a moderate debt-to-equity ratio of 1.11, indicating a balanced capital structure.
- The company's ROE of 10.13% and ROA of 4.36% suggest strong profitability relative to its equity and assets.
- The company's free cash flow is negative, which may impact its liquidity and ability to fund operations and investments.
- Amvis Holdings Inc's revenue is concentrated in Japan, exposing it to regional economic and regulatory risks.
- The company's liquidity risk is medium, with a negative net cash position after subtracting total debt.
- The company's dilution risk is low, with no significant dilution potential identified in the basic shares outstanding.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.